Rainer de Martin Selected Research

Rainer de Martin Research Topics

Disease

8	Inflammation (Inflammations) 01/2016 - 03/2004
4	Myocardial Infarction 01/2018 - 09/2011
3	Breast Neoplasms (Breast Cancer) 11/2016 - 10/2013
3	Atherosclerotic Plaque (Atheroma) 01/2016 - 09/2011
2	Heart Failure 01/2017 - 02/2015
2	Neoplasm Metastasis (Metastasis) 11/2016 - 07/2013
2	Neoplasms (Cancer) 11/2016 - 07/2013
2	Thrombosis (Thrombus) 01/2016 - 03/2004
2	Atherosclerosis 01/2016 - 08/2005
2	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 08/2015 - 01/2015
2	Melanoma (Melanoma, Malignant) 01/2015 - 02/2013
2	Vascular Diseases (Vascular Disease) 09/2009 - 04/2003
2	Hyperplasia 08/2005 - 06/2002
1	Carotid Stenosis (Carotid Artery Stenosis) 01/2016
1	Genetic Translocation (Chromosomal Translocation) 08/2015
1	Necrosis 02/2015
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 09/2014
1	Infarction (Infarctions) 09/2011
1	Cystic Fibrosis (Mucoviscidosis) 05/2006
1	Rheumatoid Arthritis 07/2003

Drug/Important Bio-Agent (IBA)

5	NF-kappa B (NF-kB)IBA 02/2013 - 07/2003
4	Proteins (Proteins, Gene)FDA Link 01/2016 - 09/2011
3	Interleukin-33IBA 01/2016 - 09/2011
3	Messenger RNA (mRNA)IBA 01/2016 - 09/2011
3	Matrix Metalloproteinases (MMPs)IBA 01/2015 - 07/2003
3	CytokinesIBA 09/2009 - 07/2003
2	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2018 - 03/2004
2	Simendan (Levosimendan)IBA 01/2017 - 02/2015
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 11/2016 - 08/2015
2	Thromboplastin (Tissue Factor)IBA 01/2016 - 03/2004
2	Anaplastic Lymphoma KinaseIBA 08/2015 - 01/2015
2	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2015 - 09/2009
2	Cadherins (E-Cadherin)IBA 01/2015 - 02/2013
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 09/2011 - 03/2004
2	I-kappa B KinaseIBA 09/2010 - 07/2003
2	Oncostatin MIBA 09/2009 - 03/2008
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 11/2016
1	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 11/2016
1	Macrophage Colony-Stimulating FactorIBA 01/2016
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2016
1	LactonesIBA 08/2015
1	Pyridinolcarbamate (P23)IBA 08/2015
1	SesquiterpenesIBA 08/2015
1	Chemotactic FactorsIBA 02/2015
1	Cisplatin (Platino)FDA LinkGeneric 01/2015
1	alpha Catenin (alpha E-Catenin)IBA 01/2015
1	thiamine triphosphorate (TTP)IBA 09/2014
1	AcidsIBA 10/2013
1	xanthohumolIBA 07/2013
1	Laminin (Merosin)IBA 02/2013
1	CateninsIBA 02/2013
1	CollagenIBA 02/2013
1	Fibronectins (Fibronectin)IBA 02/2013
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 09/2011
1	LuciferasesIBA 09/2011
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 09/2011
1	SelectinsIBA 09/2011
1	Transcription Factors (Transcription Factor)IBA 09/2010
1	Phosphotransferases (Kinase)IBA 09/2010
1	EnzymesIBA 09/2009
1	Thrombin FDA Link 09/2009
1	CalciumIBA 05/2006
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2003
1	Interleukin-6 (Interleukin 6)IBA 07/2003
1	Interleukin-8 (Interleukin 8)IBA 07/2003
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2003
1	Interleukin-1beta (Interleukin 1 beta)IBA 07/2003
1	Plasminogen Activator Inhibitor 1IBA 04/2003
1	I-kappa B Proteins (I kappa B)IBA 06/2002

Therapy/Procedure

1	Injections 09/2011
1	Therapeutics 07/2003
1	Stents 06/2002